文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肯尼亚基于药房提供的暴露前预防措施的可接受性和可行性:来自客户和提供者观点的定性研究。

Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives.

机构信息

Department of Global Health, University of Washington, 325 Ninth Avenue, Seattle, Washington, 98104, USA.

Partners in Health and Research Development, Nairobi, Kenya.

出版信息

AIDS Behav. 2021 Dec;25(12):3871-3882. doi: 10.1007/s10461-021-03229-5. Epub 2021 Apr 7.


DOI:10.1007/s10461-021-03229-5
PMID:33826022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8602157/
Abstract

As countries scale up pre-exposure prophylaxis (PrEP) for HIV prevention, diverse PrEP delivery models are needed to expand access to populations at HIV risk that are unwilling or unable to access clinic-based PrEP care. To identify factors that may influence implementation of retail pharmacy-based PrEP delivery in Kenya, we conducted in-depth interviews with 40 pharmacy clients, 16 pharmacy providers, 16 PrEP clients, and 10 PrEP providers from two provinces. Most participants expressed strong support for expanding PrEP to retail pharmacies, though conditioned their acceptance on assurances that care would be private, respectful, safe, and affordable. Participant-reported determinants of feasibility centered primarily on ensuring that the intervention is compatible with retail pharmacy operations (e.g., staffing levels, documentation requirements). Future research is needed to develop and test tailored packages of implementation strategies that are most effective at integrating PrEP delivery into routine pharmacy practice in Kenya and other high HIV prevalence settings.

摘要

随着各国扩大用于预防艾滋病毒的暴露前预防(PrEP),需要多样化的 PrEP 提供模式,以扩大获得艾滋病毒风险人群的机会,这些人群不愿意或无法获得基于诊所的 PrEP 护理。为了确定可能影响肯尼亚基于零售药店的 PrEP 提供的实施因素,我们对来自两个省份的 40 名药店客户、16 名药店提供者、16 名 PrEP 客户和 10 名 PrEP 提供者进行了深入访谈。大多数参与者强烈支持将 PrEP 扩大到零售药店,但前提是要确保护理是私密、尊重、安全和负担得起的。参与者报告的可行性决定因素主要集中在确保干预措施与零售药店的运营相兼容(例如,人员配备水平、文件要求)。需要进一步研究制定和测试有针对性的实施策略包,以最有效地将 PrEP 提供纳入肯尼亚和其他高艾滋病毒流行地区的常规药店实践。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f2/8602157/b0fe322dc41f/10461_2021_3229_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f2/8602157/b0fe322dc41f/10461_2021_3229_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f2/8602157/b0fe322dc41f/10461_2021_3229_Fig1_HTML.jpg

相似文献

[1]
Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives.

AIDS Behav. 2021-12

[2]
Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation.

BMC Health Serv Res. 2020-11-12

[3]
Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation.

J Int AIDS Soc. 2023-6

[4]
Low selection of HIV PrEP refills at private pharmacies among clients who initiated PrEP at public clinics: findings from a mixed-methods study in Kenya.

BMC Health Serv Res. 2024-5-11

[5]
The Fidelity of a Pharmacy-Based Oral HIV Pre-Exposure Prophylaxis Delivery Model in Kenya.

J Acquir Immune Defic Syndr. 2023-8-15

[6]
Measuring the performance of HIV self-testing at private pharmacies in Kenya: a cross-sectional study.

J Int AIDS Soc. 2023-10

[7]
The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub-Saharan Africa: a scoping review.

J Int AIDS Soc. 2022-10

[8]
Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.

Trials. 2024-6-19

[9]
Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions.

Curr HIV/AIDS Rep. 2024-6

[10]
PrEP distribution in pharmacies: a systematic review.

BMJ Open. 2022-2-21

引用本文的文献

[1]
Knowledge, attitudes, and willingness of healthcare workers to offer pre-exposure prophylaxis in Africa: a systematic review and meta-analysis.

AIDS Res Ther. 2025-7-18

[2]
Investigating the potential accessibility to HIV pre-exposure prophylaxis via community pharmacies and sexual health clinics: a scoping review of two integrated care systems in London.

BMC Health Serv Res. 2025-7-1

[3]
A modified pharmacy provider-led delivery model of oral HIV pre- and post-exposure prophylaxis in Kenya: a pilot study extension.

J Int AIDS Soc. 2025-6

[4]
What do women want in pharmacy-based HIV prevention services during pregnancy? Developing attributes and levels for a discrete choice experiment in Western Kenya.

AIDS Res Ther. 2025-6-4

[5]
Willingness to pay for HIV pre- and post-exposure prophylaxis services delivered via an online pharmacy in Kenya.

BMC Health Serv Res. 2025-4-22

[6]
Testing different models of pharmacy-based HIV pre- and post-exposure prophylaxis initiation and management in Kenya: protocol for a cluster-randomized controlled trial.

Res Sq. 2025-3-27

[7]
Acceptability and feasibility of the BEMPU TempWatch for hypothermia monitoring in neonatal care in Ghana: a qualitative study of clinicians' perspectives.

BMJ Public Health. 2023-10-18

[8]
Expanding the reach of HIV pre-exposure prophylaxis (PrEP) among Kenyan adolescent girls and young women: the acceptability of HIV PrEP integration into post-abortal care services.

AIDS Care. 2025-2

[9]
Development of a pharmacy-based HIV PrEP service delivery intervention for Washington, District of Columbia (DC): A study protocol.

PLoS One. 2024

[10]
Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment.

J Int AIDS Soc. 2024-7

本文引用的文献

[1]
Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: Examining concordance between pharmacy technicians and pharmacists.

J Am Pharm Assoc (2003). 2021

[2]
Pharmacy delivery to expand the reach of PrEP in Africa.

J Int AIDS Soc. 2020-9

[3]
The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review.

BMC Health Serv Res. 2020-7-31

[4]
Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study.

Lancet HIV. 2020-2-19

[5]
Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men.

J Am Pharm Assoc (2003). 2020

[6]
A Pharmacist-Led, Same-Day, HIV Pre-Exposure Prophylaxis Initiation Program to Increase PrEP Uptake and Decrease Time to PrEP Initiation.

AIDS Patient Care STDS. 2020-1

[7]
Regulating pharmacists as contraception providers: A qualitative study from Coastal Kenya on injectable contraception provision to youth.

PLoS One. 2019-12-19

[8]
Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PrEP) program in the Midwestern United States.

Open Forum Infect Dis. 2019-10-1

[9]
Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health.

J Am Pharm Assoc (2003). 2020

[10]
Iowa TelePrEP: A Public-Health-Partnered Telehealth Model for Human Immunodeficiency Virus Preexposure Prophylaxis Delivery in a Rural State.

Sex Transm Dis. 2019-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索